Mirae Asset Global ETFs Holdings’s NovoCure NVCR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Sell	94,308 -11,104	-11%	-$139K	﹤0.01%	1511
2025 Q4	$1.36M	Sell	105,412 -2,383	-2%	-$30.6K	﹤0.01%	1348
2025 Q3	$1.39M	Sell	107,795 -12	-0%	-$160	﹤0.01%	1308
2025 Q2	$1.92M	Buy	107,807 +32,815	+44%	+$572K	﹤0.01%	1115
2025 Q1	$1.34M	Buy	74,992 +2,502	+3%	+$56.8K	﹤0.01%	1350
2024 Q4	$2.16M	Buy	72,490 +1,978	+3%	+$41.9K	﹤0.01%	1087
2024 Q3	$1.1M	Buy	70,512 +58,402	+482%	+$1.06M	﹤0.01%	1487
2024 Q2	$207K	Buy	+12,110	New	+$213K	﹤0.01%	2230

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NVCR Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its NovoCure (NVCR) stake by 11% in Q1 2026, selling an estimated $139K and leaving 94,308 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Mirae Asset Global ETFs Holdings first reported a position in NVCR in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.16M in Q4 2024. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Mirae Asset Global ETFs Holdings held 94,308 shares of NovoCure worth $1.03M as of Q1 2026.
Mirae Asset Global ETFs Holdings sold 11,104 NovoCure shares in Q1 2026, an estimated $139K.
NovoCure made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1511 holding.
Mirae Asset Global ETFs Holdings first reported a position in NovoCure in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's NovoCure position peaked at $2.16M in Q4 2024.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.